High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
Petti MC, Tafuri A, Latagliata R, Aloe Spiriti MA, Montefusco E, Mancini M, Meloni G, Petrucci MT, Spadea A, Redi R, Alimena G, Mandelli F.
Petti MC, et al.
Ann Hematol. 2003 Aug;82(8):476-480. doi: 10.1007/s00277-003-0693-2. Epub 2003 Jun 26.
Ann Hematol. 2003.
PMID: 12835916